EMIT 2000 Mycophenolic Acid Assay*

MPA concentrations are highly variable in patients receiving the drug. As such, treatment needs to be individualized depending on transplant type, co-administrated drugs, time post transplant, and other factors. The EMIT® 2000 MPA assay is a simple, easy-to-use solution to help clinicians better manage MPA therapy in transplant patients.


Features

  • Results available within 10 minutes
  • Utilizes plasma samples - no pretreatment required
  • Assay can be performed alongside 3 other immunosuppressive drugs
  • Correlates to the HPLC reference method

 

Advantages

  • Streamlined ISD monitoring for enhanced productivity
  • Benefit from up to 4 different ISD methods on one single V-Twin® or Viva-E® drug testing system
     

Assay Specifications

  EMIT 2000 MPA Assay
Product Code 6R919UL
Sample Type EDTA or Heparinized plasma
Pretreatment None
Reportable Range 0.1 μg/mL–15 μg/mL
Calibration With new reagent lot
Reagent Stability Opened - until expiration date

 

Learn more about the V-Twin® and Viva-E® Drug Testing Systems


Enduring Expertise for Your Immunosuppressant Drug Testing Needs

With recognized drug testing expertise, Siemens Healthcare Diagnostics offers a comprehensive and expanding menu of tests across multiple instrument solutions to meet the immunosuppressant drug (ISD) testing needs of customers in any setting. 

*Not available for sale in the U.S.

Bu web sayfasında gösterilen ürünler/özellikler her ülkede piyasada bulunmamaktadır. Mevzuata bağlı nedenlerle gelecekte bulunabileceği garanti edilemez. Lütfen daha fazla bilgi için yerel Siemens organizasyonuyla iletişime geçiniz.